Genetic variant implicated in lung cancer development also linked with improved outcomes among affected patients

October 18, 2013
Figure 1: A mutation linked to lung cancer in Japanese women who do not smoke is also associated with better clinical outcomes. Credit: iStock/Thinkstock

Lung cancer is the most common cause of cancer death in much of the industrialized world, including Japan. While cigarette smoke is most frequently the source of the disease, genetics can also play a role. Scientists have identified a handful of genetic variants associated with an increased susceptibility to lung cancer among Asian women who do not smoke. A research team led by Toshihisa Ishikawa and colleagues from the RIKEN Center for Life Science Technologies has now identified another gene mutation that puts non-smoking Japanese women at elevated risk of lung cancer, but which is also linked to better prognosis for those who develop the disease.

Genetic variants, referred to by geneticists as (SNPs), can be useful as prognostic biomarkers for guiding diagnoses and personalizing therapies. Ishikawa and his colleagues set out to test whether variants in the NRF2 gene, which encodes a transcription factor involved in cellular antioxidant defense mechanisms, could predict the likelihood of someone developing lung cancer. The researchers analyzed DNA samples from a total of 387 Japanese lung cancer patients—43% women and 40% non-smokers—using a rapid isothermal genetic test developed specifically for this study. The team's rapid genotyping does not require DNA to be isolated or polymerase chain reaction (PCR) amplification and takes only 30–45 minutes to complete.

Looking at position –617 in the NRF2 gene, the researchers identified 24 patients who had two copies of the adenine nucleotide; the rest had at least one cytosine at this location. Of these 24 individuals, 16 were female non-smokers, and all had a type of lung cancer known as adenocarcinoma.

Notably, patients of either gender who carried two copies of adenine at position –617 of the NRF2 gene also had significantly better survival outcomes than other patients. These same individuals were more likely to carry the most common, or 'wild type', version of MDM2, a gene regulated by NRF2 that encodes a negative regulator of p53, an important tumor suppressor protein. Both the –617A variant in the NRF2 gene and the wild-type version of MDM2 are more often found in east Asian populations.

"Genetic testing of these SNPs should be performed to predict the prognosis of patients in east Asian countries, such as Japan, South Korea and China," suggests Ishikawa. "It would be desirable to include such genetic information in each patient's record as guidance for medical doctors to provide individualized treatment."

Explore further: New mutation identified, associated with better survival in lung cancer patients

More information: Okano, Y., et al. SNP (–617C>A) in ARE-like loci of the NRF2 gene: A new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women, PLoS One 8, e73794 (2013). dx.doi.org/10.1371/journal.pone.0073794

Related Stories

New mutation identified, associated with better survival in lung cancer patients

September 11, 2013
Japanese researchers have identified a mutation associated with a higher incidence of lung cancer in Japanese women who do not smoke, but better survival in lung cancer patients. In a study published today in the journal ...

Кesearchers identify gene variations that may help predict cancer treatment response

August 9, 2013
Researchers at the Moffitt Cancer Center have identified four inherited genetic variants in non-small cell lung cancer patients that can help predict survival and treatment response. Their findings could help lead to more ...

Gene variations linked to lung cancer susceptibility in Asian women

November 11, 2012
An international group of scientists has identified three genetic regions that predispose Asian women who have never smoked to lung cancer. The finding provides further evidence that risk of lung cancer among never-smokers, ...

Latest research confirms genetic susceptibility to lung cancer

April 15, 2012
Previous research has shown that Asian patients with lung cancer are more likely to harbor epidermal growth factor receptor (EGFR) mutations. Furthermore, Asian patients with lung cancer are more likely to be non-smokers ...

Scientists detail critical role of gene in many lung cancer cases

August 29, 2013
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown that a well-known cancer-causing gene implicated in a number of malignancies plays a far more critical role in non-small cell lung cancer, ...

MicroRNA molecule found to be a potent tumor-suppressor in lung cancer

September 16, 2013
New research shows that microRNA-486 is a potent tumor-suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung-cancer cells, and the induction of programmed cell death, or ...

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.